Jan 26 (Reuters) - Mycenax Biotech Inc :
* Says its new biological drug TuNEX(ENIA11) got approval from Taiwan Food and Drug Administration and will be produced and sold in Taiwan market
* TuNEX(ENIA11) is disease-modifying anti-rheumatic drug
Source text in Chinese: goo.gl/xWVC4R
Further company coverage: (Beijing Headline News)
Our Standards: The Thomson Reuters Trust Principles.